[1] Wu Q, Zhang B, Li B, et al. PTBP3 promotes migration of non-small cell lung cancer through regulating E-cadherin in EMT signaling pathway[J].Cancer Cell Int,2020,20:172.DOI:10.1186/s12935-020-01240-9.
[2] Ma J, Weng L, Jia Y, et al. PTBP3 promotes malignancy and hypoxia-induced chemoresistance in pancreatic cancer cells by ATG12 up-regulation[J].J Cell Mol Med,2020,24(5):2917-2930.DOI:10.1111/jcmm.14896.
[3] Liang X, Chen W, Shi H, et al. PTBP3 contributes to the metastasis of gastric cancer by mediating CAV1 alternative splicing[J].Cell Death Dis,2018,9(5):569.DOI:10.1038/s41419-018-0608-8.
[4] Xie C, Long F, Li L, et al. PTBP3 modulates P53 expression and promotes colorectal cancer cell proliferation by maintaining UBE4A mRNA stability[J].Cell Death Dis,2022,13(2):128.DOI:10.1038/s41419-022-04564-8.
[5] Hu J, Qian H, Xue Y, et al. PTB/nPTB: master regulators of neuronal fate in mammals[J].Biophys Rep,2018,4(4):204-214.DOI:10.1007/s41048-018-0066-y.
[6] Spellman R, Llorian M, Smith CW. Crossregulation and functional redundancy between the splicing regulator PTB and its paralogs nPTB and ROD1[J].Mol Cell,2007,27(3):420-434.DOI:10.1016/j.molcel.2007.06.016.
[7] Yamamoto H, Tsukahara K, Kanaoka Y, et al. Isolation of a mammalian homologue of a fission yeast differentiation regulator[J].Mol Cell Biol,1999,19(5):3829-3841.DOI:10.1128/MCB.19.5.3829.
[8] Dong C, Wu K, Gu S, et al. PTBP3 mediates TGF-β-induced EMT and metastasis of lung adenocarcinoma[J].Cell Cycle,2022,21(13):1406-1421.DOI:10.1080/15384101.2022. 2052530.
[9] Hou P, Li L, Chen F, et al. PTBP3-mediated regulation of ZEB1 mRNA stability promotes epithelial-mesenchymal transition in breast cancer[J].Cancer Res,2018,78(2):387-398.DOI:10.1158/0008-5472.CAN-17-0883.
[10] Zhang S, Lai N, Liao K, et al. MicroRNA-210 regulates cell proliferation and apoptosis by targeting regulator of differentiation 1 in glioblastoma cells[J].Folia Neuropathol,2015,53(3):236-244.DOI:10.5114/fn. 2015.54424.
[11] Chen B, Chen W, Mu X, et al. PTBP3 induced inhibition of differentiation of gastric cancer cells through alternative splicing of Id1[J].Front Oncol,2020,10:1477.DOI:10.3389/fonc.2020.01477.
[12] Liang X, Shi H, Yang L, et al. Inhibition of polypyrimidine tract-binding protein 3 induces apoptosis and cell cycle arrest, and enhances the cytotoxicity of 5- fluorouracil in gastric cancer cells[J].Br J Cancer,2017,116(7):903-911.DOI:10.1038/bjc.2017.32.
[13] Hou P, Chen F, Yong H, et al. PTBP3 contributes to colorectal cancer growth and metastasis via translational activation of HIF-1α[J].J Exp Clin Cancer Res,2019,38(1):301.DOI:10.1186/s13046-019-1312-y.
[14] Treiber T, Treiber N, Plessmann U, et al. A compendium of RNA-binding proteins that regulate microRNA biogenesis[J].Mol Cell,2017,66(2):270-284.e13.DOI:10.1016/j.molcel.2017.03.014.
[15] Xu M, Tian GL, Hao CC, et al. MicroRNA-29 targets FGF2 and inhibits the proliferation, migration and invasion of nasopharyngeal carcinoma cells via PI3K/AKT signaling pathway[J].Eur Rev Med Pharmacol Sci,2020,24(13):7199.DOI:10.26355/eurrev_202007_21849.
[16] Guo D, Jin J, Liu J, et al. MicroRNA-29b regulates the radiosensitivity of esophageal squamous cell carcinoma by regulating the BTG2-mediated cell cycle[J].Strahlenther Onkol,2021,197(9):829-835.DOI:10.1007/s00066-021-01790-5.
[17] 王江峰,凌志强,毛伟敏.MicroRNA-29b在食管鳞状细胞癌中的表达及临床意义[J].实用肿瘤杂志,2013,28(05):481-484.DOI:10.13267/j.cnki.syzlzz.2013.05.013.
[18] Kwon JJ, Factora TD, Dey S, et al. A systematic review of miR-29 in cancer[J].Mol Ther Oncolytics,2018,12:173-194.DOI:10.1016/j.omto.2018.12.011.
[19] Landgraf P, Rusu M, Sheridan R, et al. A mammalian microRNA expression atlas based on small RNA library sequencing[J].Cell,2007,129(7):1401-1414.DOI:10.1016/j.cell.2007.04.040.
|